Project Grant R03NS133674
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Tulane University $624,329 under its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on September 9, 2025, with a completion date of July 31, 2030. This Project Grant funds research to develop an efficient delivery system for nerve growth factor (NGF) variants to treat spinal cord injuries (SCIs). The project addresses a critical clinical...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $470,293 to The Research Foundation For The State University of New York (SUNY at Binghamton) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025, through June 30, 2027. This Project Grant funds research aimed at identifying and characterizing the electrophysiological features of spinal motor neurons during...
- Federal Grant Award Summary Microcures Inc. received a Project Grant award of $961,052 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 15, 2025 through April 30, 2027. The award funds proof-of-feasibility studies and therapeutic development for a nanoparticle-encapsulated siRNA (small interfering RNA) formulation designed to target Fidgetin-like 2...
- Federal Project Grant Award Summary The Winifred Masterson Burke Medical Research Institute, Inc. received a $492,250 Project Grant award dated July 3, 2025, from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports a two-year research project through June 30, 2027, investigating the role of SPARC (Secreted Protein Acidic and Cysteine Rich) in wound...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $451,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective August 1, 2025, through July 31, 2027. This high-risk, high-reward research initiative aims to develop innovative therapeutic strategies for spinal cord injury (SCI) by converting...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded New Jersey Institute of Technology $553,292 on March 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This three-year project grant, concluding February 28, 2029, supports the development of an in vitro three-dimensional (3D) tissue construct system to study peripheral nerve regeneration and axonal growth. The...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Salk Institute for Biological Studies a $2.27 million Project Grant (CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders) effective August 1, 2025, through June 30, 2030, to support research characterizing spinal neural activity during hindlimb motor behaviors in mice. The primary deliverable involves recording and analyzing firing patterns of spinal...
- Federal Project Grant Award Summary The University of Louisville's Office of Research & Innovation received a $1,149,156 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded May 5, 2025, with completion targeted for March 31, 2030. The award supports research investigating cell type-specific effects of the integrated stress response (ISR)...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded The Leland Stanford Junior University a $428,089 Project Grant effective April 1, 2026, through March 31, 2028. This award supports the development of protein-based conductive, injectable, biodegradable hydrogels designed for tissue regeneration applications. The...
- This $424,875.00 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund a comprehensive study of gene transcription patterns in diverse classes of neurons that connect the brain to the spinal cord after spinal cord injury in a mouse model. The research team at Marquette University will use single-cell sequencing technologies to profile...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $151,559 to Rensselaer Polytechnic Institute (RPI) from August 3, 2024 to July 31, 2026. The project aims to develop innovative magnetically responsive drug delivery electrospun fibers to improve regeneration after spinal cord injury (SCI). Specifically, the research will focus on fabricating magnetic, growth factor-loaded coaxial electrospun fibers that can be stimulated non-invasively with a magnetic field to control the release rate of transforming growth factor beta 3 (TGF-β3) to mitigate astrocyte reactivity and more effectively treat the unique inflammatory response of individual SCI patients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $151.6k | 8/2/24 |